AMEX : CCEL
$0.03 (0.84%)
AMEX
David Portnoy
Medical - Care Facilities
Healthcare
CCEL
76
US
USD
-0.50
0.71
0.69
0.03
0.00
$31.57M
0.93
-1.63
4.75
0.76
-$0.3
-$2.43M
-7.92%
-8.19%
14.18%
-4.06%
-12.24
0.55
0.55
$8.50
$8.50
$8.50
1/5
1 Analysts
-57.65%
-0.27
6/9
-$4.63M
$60.71M
$78.46M
-$623.09K
$37.48M
1.20
159.59
0.71
14.18%
-0.22%
-8.50%
21.05%
-50 days
| Name | Title |
|---|---|
| Joanne Kurtzberg | Medical Director and Member of Medical & Scientific Advisory Board |
| Mark L. Portnoy | Co-CEO & Director |
| Oleg Mikulinsky | Chief Information Officer |
| David I. Portnoy | Chairman & Co-CEO |
| Jill Taymans | Chief Financial Officer & Vice President of Finance |
No votes yet today — be the first to share your view!
About Cryo-Cell International, Inc. (AMEX:CCEL) Stock
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, chi ... ldbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2026 Financial Results
2026-07-15 16:30:00
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal second quarter ended May 31, 2026. Financial Results Revenue The revenues for the second quarter of fiscal 2026 were $7.8 million compared to $7.9 million for the second quarter of fiscal 2025, a 2% decrease. The revenues for the second quarter of fiscal 2026 consisted of $7.7.
Frequently Asked Questions
What is the current Cryo-Cell International, Inc. (CCEL) stock price?
Cryo-Cell International, Inc.(AMEX:CCEL) stock price is $3.6 in the last trading session. During the trading session, CCEL stock reached the peak price of $5.01 while $2.72 was the lowest point it dropped to. The percentage change in CCEL stock occurred in the recent session was 0.84% while the dollar amount for the price change in CCEL stock was $0.03.
CCEL's industry and sector of operation?
The AMEX listed CCEL is part of Medical - Care Facilities industry that operates in the broader Healthcare sector.
Who are the executives of CCEL?
Joanne Kurtzberg
| Medical Director and Member of Medical & Scientific Advisory Board
Mark L. Portnoy
| Co-CEO & Director
Oleg Mikulinsky
| Chief Information Officer
David I. Portnoy
| Chairman & Co-CEO
Jill Taymans
| Chief Financial Officer & Vice President of Finance
How many employees does CCEL have?
Number of CCEL employees currently stands at 76. CCEL operates from 700 Brooker Creek Boulevard, Oldsmar, FL 34677, US.
Link for CCEL official website?
Official Website of CCEL is: https://www.cryo-cell.com
How do I contact CCEL?
CCEL could be contacted at phone #813 749 2100 and can also be accessed through its website. CCEL operates from 700 Brooker Creek Boulevard, Oldsmar, FL 34677, US.
How many shares of CCEL are traded daily?
The average number of CCEL shares traded daily for last 3 months was 9.35K.
What is the market cap of CCEL currently?
The market value of CCEL currently stands at $29.03M with its latest stock price at $3.6